Quarterly Results for the Q.E. 31-12-2024

Standalone Unaudited Financials for Q ended 31.12.2024 Pursuant to sale of 100 % Investment in wholly owned subisidary Company ,Sandu Pharmaceuticals Limited is not Required to do Consolidation of Financials for December 2024 and onwards

As per the letter attached.

Un-audited results of the company for the quarter ended 31-12-2024

Un-audited financial results of the company for the quarter and nine months ended on December 31, 2024

Pursuant to provisions of Regulation 33, the Board approved the Standalone Unaudited Financial Results for the Quarter ended December 31, 2024

Approval of results for the quarter ended on 31st december, 2024

Please find enclosed the Un-audited Financial Results for the Quarter/Nine-Months ended December 31, 2024 declared at the Board Meeting today

Un-Audited Financial Results for the quarter ended on 31st December, 2024

Unaudited Financial Results for the quarter ended December 2024.